about
Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model.Differential arthritogenicity of Staphylococcus aureus strains isolated from biological samples.Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis.Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 productionDietary restriction abrogates antibody production induced by a DNA vaccine encoding the mycobacterial 65 kDa heat shock protein.BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.Previous infection with Staphylococcus aureus strains attenuated experimental encephalomyelitis.pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity.Immunomodulation in human and experimental arthritis: including vitamin D, helminths and heat-shock proteins.Vitamin D Deficiency and Rheumatoid Arthritis.Prevention of experimental diabetes by Uncaria tomentosa extract: Th2 polarization, regulatory T cell preservation or both?Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.Cloxacillin control of experimental arthritis induced by SEC(+) Staphylococcus aureus is associated with downmodulation of local and systemic cytokines.Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis.Correction: Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis.Faecal examination and PCR to detect Strongyloides venezuelensis in experimentally infected Lewis rats.Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes.Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog.Bacille Calmette-Guérin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes.Migratory route of Strongyloides venezuelensis in Lewis rats: comparison of histological analyses and PCR.Zinc Supplementation Attenuates Cardiac Remodeling After Experimental Myocardial InfarctionRecovery from Strongyloides venezuelensis infection in Lewis rats is associated with a strong Th2 responseExperimental autoimmune encephalomyelitis evolution was not modified by multiple infections with Strongyloides venezuelensisDownmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNSPeptidylarginine deiminase 4 concentration, but not PADI4 polymorphisms, is associated with ICU mortality in septic shock patientsA serine protease inhibitor suppresses autoimmune neuroinflammation by activating the STING/IFN-β axis in macrophagesC57BL/6 and DBA/1 Mice Differ in Their Response to Supplementation with 1,25D and ParicalcitolGliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering NeuroinflammationCalming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
P50
Q33757939-3A79555E-8DB4-45AD-82D4-83E0EBBFCA41Q34976399-79145C64-80EE-44D9-B663-54161B6EA7BFQ35597747-A281C203-3F24-471C-A6BB-3DA659476BDEQ36953054-CB92D0A8-9111-406E-8793-0B10438F5ACCQ37010063-3DB9EB82-F87B-4700-A845-E57CC48BA5BEQ37281418-23466AFE-B1BB-4461-B821-6DD365F1B9F1Q37316205-94306325-B257-4821-9214-AAB1A0ABCCACQ37474212-322367AF-1C54-4AFE-B2C6-FBD87A6DDDB6Q37683473-24EB11F1-3AE4-4562-B347-FCA8EED09A7DQ38206949-669457D5-B3E4-4D96-935F-02AE3E0ECF57Q38916397-6ED3FBAA-F197-4FA5-AE78-EA19D30139FDQ38975598-3B5AC65A-245C-4A8F-A826-6BBD98815B08Q39777527-CEEB6CAB-54FB-4F73-884B-05BA47DA5260Q40112349-4CADC0FE-649B-4D82-B696-EEFAF2AE8FC2Q40860604-F7583982-9C75-4ED1-8F87-DF74CA222259Q42102122-C64396FC-69A2-4235-9AB7-C1C9B0712B49Q42350924-B62BBACB-9402-4A4B-87B3-E54656EE915CQ44014343-55CFA48F-DABD-4C25-901D-15C132825AE8Q44061763-4DB0BC17-D74E-4B75-BF36-A60642FEFFA4Q46438033-EC92641B-2597-4E19-9F38-306781FCE86BQ50974904-7CE1F6FE-144D-4785-A3A9-2A69006BB1C0Q54413658-F7222135-88ED-4CC3-BC15-1347959A1D1EQ57025416-A44E0F50-038A-40B3-885F-B230E8FAF7F6Q82367715-CC46614C-31B8-467D-86EB-74185609A7B8Q83814777-851239DA-9889-49A3-A40A-8924863D957FQ87121531-8A03D168-0EB8-4641-A296-48B2A30A9B56Q90465687-D54B6871-C49A-4014-ADE6-F8BAB8E12545Q90589895-C279BB84-61DA-4B52-A230-BAAE7DDDA646Q91551818-8219FDCF-3C8F-41AF-8B1E-9B88B8960654Q92256800-4096F436-2019-41F2-91E1-8950DA123194Q92971633-498B24D2-B6CE-4F0A-B31F-633DEF1B401B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
L L W Ishikawa
@en
L L W Ishikawa
@nl
type
label
L L W Ishikawa
@en
L L W Ishikawa
@nl
prefLabel
L L W Ishikawa
@en
L L W Ishikawa
@nl
P108
P31
P496
0000-0003-3481-2181